ACEI/ARB Underused in Patients with Type 2 Diabetes in Chinese Population (CCMR-3B Study)

201516 citationsJournal Articlegold Open Access

Authors

Qionghong Xie · Fudan University

Chuan‐Ming Hao · Fudan University

Linong Ji · Peking University

Dayi Hu · Peking University

Tongying Zhu · Huashan Hospital

Xuehai Li · VitalStrategic Research Institute

Dandan Qin · VitalStrategic Research Institute

Abstract

In T2DM with hypertension and albuminuria in China, more than half of them were not treated with ACEI/ARB. This real world evidence suggests that the current treatment for patients with diabetes coexisting with hypertension and albuminuria in China is sub-optimal.

Topics & Keywords

Blood Pressure and Hypertension Studies Diabetes Treatment and Management Antiplatelet Therapy and Cardiovascular Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PLoS ONE

Volume 10, Issue 2, pp. e0116970-e0116970

DOI: 10.1371/journal.pone.0116970

Field-Weighted Citation Impact: 1.06